This compound is a Boc-protected pharmaceutical intermediate featuring a purine core linked to a piperidine ring and a quinazoline group. It is primarily used in the synthesis of more complex active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 668273-75-4
Tert-Butyl 6,7-dihydrothieno[3,2-c]pyridine-5(4H)-carboxylate
pharmaceutical intermediate
(S)-tert-Butyl (1-oxo-1-phenylhex-5-yn-2-yl)carbamate
pharmaceutical intermediate
2-Chloropyridine-3-sulfonyl chloride
pharmaceutical intermediate
Calcium DL-3-methyl-2-oxovalerate
pharmaceutical intermediate
1-Methylcyclopropane-1-sulfonamide
pharmaceutical intermediate
2-Chloro-5-methylnicotinic acid
pharmaceutical intermediate
LINAGLIPTIN, (S)-
pharmaceutical raw material
Linagliptin
pharmaceutical raw material
tert-butyl N-[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]carbamate
PQEIZFATTRGTNW-HXUWFJFHSA-N
CC#CCN1C2=C(N=C1N3CCC[C@H](C3)NC(=O)OC(C)(C)C)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C